Amylyx Pharmaceuticals has ridden a wave of high-profile wins and setbacks in recent years. Now, the company is gearing up for another pivotal moment — a key readout that could largely determine its fate.
Within the next few months, Amylyx plans to finish recruitment for a pivotal study of its late-stage candidate…